jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Vitamin E

Vitamin
image

Report in 120Hrs

image

At Home

fastingrequire

Fasting Required

Details

Measures vitamin levels.

5,9618,516

30% OFF

Vitamin E Test Information Guide

  • Why is it done?
    • Measures serum levels of vitamin E (tocopherol), a fat-soluble antioxidant essential for protecting cells from oxidative damage
    • Diagnose vitamin E deficiency, which may cause neurological symptoms, muscle weakness, and vision problems
    • Evaluate patients with malabsorption disorders such as cystic fibrosis, celiac disease, Crohn's disease, or cholestasis
    • Assess patients with neurological disorders, including ataxia, peripheral neuropathy, or cognitive decline
    • Monitor vitamin E status in patients on long-term total parenteral nutrition (TPN) or with chronic liver disease
    • Investigate patients with genetic conditions affecting fat absorption, such as abetalipoproteinemia
    • Evaluate hemolytic anemia and retinopathy in premature infants
    • Typically performed during annual physical examinations, when malabsorption is suspected, or when patients report neurological symptoms
  • Normal Range
    • Normal range: 5.5 to 17.0 μmol/L (or approximately 2.4 to 7.3 mg/mL)
    • Reference ranges may vary slightly between laboratories and testing methods
    • Units of measurement: Micromoles per liter (μmol/L) or milligrams per liter (mg/mL)
    • Low values (below 5.5 μmol/L): Indicate vitamin E deficiency with potential for clinical manifestations
    • High values (above 17.0 μmol/L): May occur from excessive supplementation but generally well-tolerated; normal with dietary sources
    • Results should be interpreted in clinical context, considering patient symptoms and risk factors for deficiency
  • Interpretation
    • Low Vitamin E Levels (< 5.5 μmol/L): Indicates deficiency requiring clinical attention and potential supplementation; may manifest as neurological symptoms, muscle weakness, or vision problems; commonly seen in malabsorption disorders
    • Normal Vitamin E Levels (5.5-17.0 μmol/L): Indicates adequate vitamin E status and sufficient antioxidant protection; no supplementation typically needed unless risk factors present
    • High Vitamin E Levels (> 17.0 μmol/L): Usually benign and may result from supplementation; excessive intake from supplements may increase bleeding risk in patients on anticoagulants; generally not toxic but may warrant review of supplement intake
    • Borderline Low Values (5.5-8.0 μmol/L): May warrant monitoring and dietary assessment; consider supplementation if patient has risk factors or symptoms; repeat testing recommended if clinical suspicion high
    • Factors Affecting Results:
    • Dietary intake varies with consumption of nuts, seeds, vegetable oils, and fortified foods; fat malabsorption significantly impacts levels; cholestasis and liver disease reduce absorption and storage; genetic mutations affecting lipid transport; medications affecting fat absorption
    • Clinical Significance:
    • Deficiency can cause spinocerebellar ataxia, peripheral neuropathy, myopathy, and retinopathy; in infants, may cause hemolytic anemia and retinopathy of prematurity; chronic deficiency increases oxidative stress and risk of neurodegeneration; correction of deficiency can halt progression of neurological symptoms
  • Associated Organs
    • Primary Organ Systems:
    • Nervous system: Central and peripheral nervous system most vulnerable to vitamin E deficiency; neurological manifestations include ataxia, neuropathy, and cognitive decline
    • Liver: Primary organ for vitamin E metabolism and storage; impaired function affects levels
    • Gastrointestinal tract: Site of absorption; fat malabsorption directly impacts vitamin E uptake
    • Eyes: Vitamin E protects against oxidative damage; deficiency can cause retinopathy
    • Associated Medical Conditions:
    • Cystic fibrosis: Pancreatic insufficiency and fat malabsorption lead to deficiency
    • Celiac disease and inflammatory bowel disease: Mucosal damage impairs absorption
    • Cholestatic liver disease: Reduced bile production affects fat-soluble vitamin absorption
    • Abetalipoproteinemia: Genetic disorder preventing fat transport; severe deficiency common
    • Chronic pancreatitis: Pancreatic dysfunction impairs fat digestion and absorption
    • Premature infants: Underdeveloped absorption systems increase risk of deficiency
    • Complications Associated with Deficiency:
    • Progressive neurological deterioration if untreated; permanent motor neuron damage; vision loss from retinopathy
    • Hemolytic anemia in infants; increased infection risk; accelerated aging of cells from oxidative stress
  • Follow-up Tests
    • If Deficiency Identified:
    • Serum lipid panel: Assess total cholesterol and triglycerides; vitamin E transport depends on lipoproteins
    • Liver function tests: Evaluate hepatic metabolism and storage capacity for vitamin E
    • Fat-soluble vitamin panel: Assess for deficiencies of vitamins A, D, and K; co-deficiencies common in malabsorption
    • Immunoglobulin A (IgA) and tissue transglutaminase (tTG): Screen for celiac disease if not previously diagnosed
    • Genetic testing: Consider if abetalipoproteinemia or other genetic lipid disorders suspected
    • If Malabsorption Identified:
    • 72-hour fecal fat test: Quantifies steatorrhea and confirms fat malabsorption
    • Fecal chymotrypsin or elastase: Assesses pancreatic function
    • Upper endoscopy with small bowel biopsy: If inflammatory bowel disease or celiac disease suspected
    • For Neurological Symptoms:
    • Nerve conduction studies (NCS) and electromyography (EMG): Evaluate peripheral neuropathy
    • MRI of brain and spinal cord: Assess for structural changes related to ataxia or neurological deficits
    • Ophthalmologic examination: Screen for retinopathy or vision problems
    • Monitoring During Treatment:
    • Repeat vitamin E testing: After 2-3 months of supplementation to assess treatment response; then annually to monitor adequacy
    • Regular clinical assessment: Monitor for resolution of neurological symptoms and prevention of progression
    • Monitoring frequency: Every 6-12 months for patients on long-term supplementation or with chronic malabsorption
  • Fasting Required?
    • Fasting Status: No, fasting is not required for the vitamin E test
    • Sample Collection:
    • Blood sample collected by venipuncture into a standard serum separator tube or gold-top tube
    • Specimen should be kept at room temperature until processing; protected from light exposure
    • Medication Considerations:
    • No specific medications need to be discontinued before testing
    • Vitamin E supplements should be continued unless specifically instructed otherwise; inform provider of supplement use
    • If assessing baseline status, it may be beneficial to wait at least 2-3 weeks after discontinuing supplements for accurate deficiency assessment
    • Other Patient Preparation:
    • No special restrictions on food or beverage intake before testing
    • Arrive adequately hydrated for easier blood draw
    • Inform healthcare provider of current dietary intake, supplements, and any gastrointestinal or absorption issues
    • Report any medications that affect fat absorption (such as cholesterol-lowering drugs or pancreatic enzymes)
    • Testing can typically be done at any time of day without special timing requirements

How our test process works!

customers
customers